Back to User profile » Dr Mahmoud Abunasser

Papers published by Dr Mahmoud Abunasser:

Thromboembolic Events in Patients with HER2-Negative, Hormone Receptor-Positive, Metastatic Breast Cancer Treated with Ribociclib Combined with Letrozole or Fulvestrant: A Real-World Data

Abdel-Razeq H, Sharaf B, AlMasri R, Abdel-Razeq R, Tamimi F, Khader O, Salama O, Abunasser M, Edaily S, Abdulelah H

Cancer Management and Research 2022, 14:1033-1041

Published Date: 8 March 2022

Patterns and Prevalence of BRCA1 and BRCA2 Germline Mutations Among Patients with Triple-Negative Breast Cancer: Regional Perspectives

Abdel-Razeq H, Tamimi F, Abujamous L, Edaily S, Abunasser M, Bater R, Salama O

Cancer Management and Research 2021, 13:4597-4604

Published Date: 9 June 2021

Clinicopathological Characteristics And Treatment Outcomes Of Breast Cancer Among Adolescents And Young Adults In A Developing Country

Abdel-Razeq H, Almasri H, Abdel Rahman F, Abdulelah H, Abu Nasser M, Salam M, Al-Dairi A, Natour O, Rimawi D

Cancer Management and Research 2019, 11:9891-9897

Published Date: 22 November 2019

Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients

Abdel-Razeq H, Saadeh SS, Abu-Nasser M, Abdulelah H, Marie L, Salam M, Al-Haj Ali B, Ibrahim M, Rimawi D

OncoTargets and Therapy 2018, 11:2091-2096

Published Date: 11 April 2018

The application of clinical variables and models to predict pulmonary embolism in cancer patients: a comprehensive single cancer center experience

Mansour A, Ismael Y, Abunasser M, Hammode E, Turfa R, Abdel-Razeq H

Patient Preference and Adherence 2013, 7:1111-1116

Published Date: 23 October 2013